Pharma Battle at Standstill, But War Is Far From Over

“All’s quiet on the Western front, but we’re still in the war.” That's how John Kamp, executive director of the Coalition for Healthcare Communication, summed up the pharmaceutical industry’s regulatory issues. Big Pharma’s annual tussles with the Food and Drug Administration, not to mention Congress, seem to be at a standstill thanks to the coming presidential election. But both sides are gearing up for what could be an eventful winter.
Advertising Age